Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review)

Overview

Journal Sovrem Tekhnologii Med

Specialties Biomedical Engineering
General Medicine

Date 2021 Oct 4

PMID 34603757

Citations 29

Authors

t a Karmakova

N S Sergeeva

k Yu Kanukoev

B Ya Alekseev

A D Kaprin

Affiliations

Soon will be listed here.

Abstract

KIM-1 (kidney injury molecule 1) is a transmembrane glycoprotein also known as HAVcr-1 and TIM-1 belongs to the T-cell immunoglobulin and mucin domain family (TIM) of proteins. TIM glycoproteins are presented on the immune cells and participate in the regulation of immune reactions. KIM-1 differs from other members of its family in that it is expressed not only by immunocompetent cells but epithelial cells as well. Cellular and humoral effects mediated by KIM-1 are involved in a variety of physiological and pathophysiological processes. Current understanding of the mechanisms determining the participation of KIM-1 in viral invasion, the immune response regulation, adaptive reactions of the kidney epithelium to acute ischemic or toxic injury, in progression of chronic renal diseases, and kidney cancer development have been presented in this review. Data of clinical researches demonstrating the association of KIM-1 with viral diseases and immune disorders have also been analyzed. Potential application of KIM-1 as urinary or serological marker in renal and cardiovascular diseases has been considered.

Citing Articles

High-density lipoprotein nanoparticles spontaneously target to damaged renal tubules and alleviate renal fibrosis by remodeling the fibrotic niches.

He S, Li X, He Y, Guo L, Dong Y, Wang L Nat Commun. 2025; 16(1):1061.

PMID: 39870661 PMC: 11772610. DOI: 10.1038/s41467-025-56223-z.

The Evaluation of Serum KIM-1 in a Pediatric Cohort of Renal Transplantation-A Pilot Study.

Aldea P, Turbuleasa-Jurje R, Bulata B, Delean D, Elec F, Ciumarnean L Children (Basel). 2025; 12(1).

PMID: 39857894 PMC: 11764347. DOI: 10.3390/children12010063.

Monascus red pigment influence on hydroxyapatite nanoparticles-mediated renal toxicity in rats.

Alqurashy N, Yousef M, Hussein A, Kamel M, El Wakil A Sci Rep. 2025; 15(1):2715.

PMID: 39837868 PMC: 11750980. DOI: 10.1038/s41598-024-84959-z.

Predictive Value of Urinary KIM-1, TIMP-2 and sTREM-1 for Contrast-Induced Acute Kidney Injury in Elderly Patients After Percutaneous Coronary Intervention.

Huang W, Wang R, Zhang P Int J Gen Med. 2025; 18():145-152.

PMID: 39822263 PMC: 11735412. DOI: 10.2147/IJGM.S495766.

Evaluating Neutrophil Gelatinase-Associated Lipocalin in Pediatric CKD: Correlations with Renal Function and Mineral Metabolism.

Steflea R, Stoicescu E, Aburel O, Horhat F, Vlad S, Bratosin F Pediatr Rep. 2024; 16(4):1099-1114.

PMID: 39728735 PMC: 11676301. DOI: 10.3390/pediatric16040094.

References

Biasin M, Sironi M, Saulle I, Pontremoli C, Garziano M, Cagliani R . A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infection. Microbes Infect. 2016; 19(1):69-74. DOI: 10.1016/j.micinf.2016.09.005. View

Wybraniec M, Chudek J, Bozentowicz-Wikarek M, Mizia-Stec K . Prediction of contrast-induced acute kidney injury by early post-procedural analysis of urinary biomarkers and intra-renal Doppler flow indices in patients undergoing coronary angiography. J Interv Cardiol. 2017; 30(5):465-472. DOI: 10.1111/joic.12404. View

Telford E, Jiang W, Martin T . HAVcR-1 involvement in cancer progression. Histol Histopathol. 2016; 32(2):121-128. DOI: 10.14670/HH-11-817. View

Tu Y, Wang H, Sun R, Ni Y, Ma L, Xv F . Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Ren Fail. 2014; 36(10):1559-63. DOI: 10.3109/0886022X.2014.949764. View

Emmens J, Ter Maaten J, Matsue Y, Metra M, OConnor C, Ponikowski P . Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. Eur J Heart Fail. 2015; 18(6):641-9. DOI: 10.1002/ejhf.426. View

Wybraniec M, Chudek J, Mizia-Stec K . Association between elevated urinary levels of kidney injury molecule type 1 and adverse cardiovascular events at 12 months in patients with coronary artery disease. Pol Arch Intern Med. 2018; 128(5):301-309. DOI: 10.20452/pamw.4242. View

Shahbaz S, Pourrezagholi F, Nafar M, Ahmadpoor P, Barabadi M, Foroughi F . Dynamic variation of kidney injury molecule-1 mRNA and protein expression in blood and urine of renal transplant recipients: a cohort study. Clin Exp Nephrol. 2019; 23(10):1235-1249. DOI: 10.1007/s10157-019-01765-y. View

Yamanishi Y, Kitaura J, Izawa K, Kaitani A, Komeno Y, Nakamura M . TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J Exp Med. 2010; 207(7):1501-11. PMC: 2901072. DOI: 10.1084/jem.20090581. View

Ibrahim N, McCarthy C, Shrestha S, Lyass A, Li Y, Gaggin H . Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. Am Heart J. 2019; 209:36-46. DOI: 10.1016/j.ahj.2018.12.001. View

10.

Xue J, Li Y, Yi J, Jiang H . HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Gastroenterol Res Pract. 2019; 2019:6746970. PMC: 6914876. DOI: 10.1155/2019/6746970. View

11.

Martin T, Harrison G, Mason M, Jiang W . HAVcR-1 reduces the integrity of human endothelial tight junctions. Anticancer Res. 2011; 31(2):467-73. View

12.

McIntire J, Umetsu S, Akbari O, Potter M, Kuchroo V, Barsh G . Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol. 2001; 2(12):1109-16. DOI: 10.1038/ni739. View

13.

Xu P, Zhang J, Chen M, Lv J, Liu G, Zou W . Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Nephrol Dial Transplant. 2011; 26(10):3229-36. DOI: 10.1093/ndt/gfr023. View

14.

Bonventre J . Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009; 24(11):3265-8. DOI: 10.1093/ndt/gfp010. View

15.

Chazot R, Botelho-Nevers E, Fresard A, Maillard N, Mariat C, Lucht F . Diagnostic challenges of kidney diseases in HIV-infected patients. Expert Rev Anti Infect Ther. 2017; 15(10):903-915. DOI: 10.1080/14787210.2017.1379395. View

16.

Vaidya V, Ozer J, Dieterle F, Collings F, Ramirez V, Troth S . Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 2010; 28(5):478-85. PMC: 2885849. DOI: 10.1038/nbt.1623. View

17.

George B, Joy M, Aleksunes L . Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. Exp Biol Med (Maywood). 2017; 243(3):272-282. PMC: 5813872. DOI: 10.1177/1535370217745302. View

18.

Li Z, Shen C, Wang Y, Wang W, Zhao Q, Liu Z . Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B. Medicine (Baltimore). 2016; 95(44):e5264. PMC: 5591140. DOI: 10.1097/MD.0000000000005264. View

19.

Wilker P, Sedy J, Grigura V, Murphy T, Murphy K . Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family. Int Immunol. 2007; 19(6):763-73. DOI: 10.1093/intimm/dxm044. View

20.

Egli P, Aeschbacher S, Bossard M, Eggimann L, Blum S, Meyre P . Relationships of kidney injury molecule-1 with renal function and cardiovascular risk factors in the general population. Clin Chim Acta. 2017; 478:13-17. DOI: 10.1016/j.cca.2017.12.019. View